CURRENT STATE OF LIPOSOME-COMPLEXED DRUGS IN THE TREATMENT OF CANCER-PATIENTS

EGE DEVRIES; NH MULDER; T DAEMEN

CURRENT STATE OF LIPOSOME-COMPLEXED DRUGS IN THE TREATMENT OF CANCER-PATIENTS

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	419-421
Number of pages	3
Journal	Annals of Oncology
Volume	3
Issue number	6
Publication status	Published - Jun-1992

Keywords

MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE
PHASE-I
TUMORICIDAL PROPERTIES
ENCAPSULATED DOXORUBICIN
INTRAVENOUS-INJECTION
ALVEOLAR MACROPHAGES
INVITRO ACTIVATION
CLINICAL-TRIAL
DIPEPTIDE
MITOXANTRONE

Handle.net

Persistent link

Cite this

@article{d5f6295002604e3ab7e944fc5861306b,

title = "CURRENT STATE OF LIPOSOME-COMPLEXED DRUGS IN THE TREATMENT OF CANCER-PATIENTS",

keywords = "MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE, PHASE-I, TUMORICIDAL PROPERTIES, ENCAPSULATED DOXORUBICIN, INTRAVENOUS-INJECTION, ALVEOLAR MACROPHAGES, INVITRO ACTIVATION, CLINICAL-TRIAL, DIPEPTIDE, MITOXANTRONE",

author = "EGE DEVRIES and NH MULDER and T DAEMEN",

year = "1992",

month = jun,

language = "English",

volume = "3",

pages = "419--421",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - CURRENT STATE OF LIPOSOME-COMPLEXED DRUGS IN THE TREATMENT OF CANCER-PATIENTS

AU - DEVRIES, EGE

AU - MULDER, NH

AU - DAEMEN, T

PY - 1992/6

Y1 - 1992/6

KW - MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE

KW - PHASE-I

KW - TUMORICIDAL PROPERTIES

KW - ENCAPSULATED DOXORUBICIN

KW - INTRAVENOUS-INJECTION

KW - ALVEOLAR MACROPHAGES

KW - INVITRO ACTIVATION

KW - CLINICAL-TRIAL

KW - DIPEPTIDE

KW - MITOXANTRONE

M3 - Editorial

SN - 0923-7534

VL - 3

SP - 419

EP - 421

JO - Annals of Oncology

JF - Annals of Oncology

IS - 6

ER -